Lionshead Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.91M Buy
3,811
+1,993
+110% +$957K 1.24% 25
2026
Q1
$894K Sell
1,818
-7
-0.4% -$3.8K 0.66% 39
2025
Q4
$1.06M Buy
1,825
+13
+0.7% +$7.35K 0.79% 37
2025
Q3
$879K Buy
1,812
+24
+1% +$11.2K 0.7% 37
2025
Q2
$726K Buy
1,788
+1,034
+137% +$432K 0.67% 42
2025
Q1
$376K Sell
754
-103
-12% -$55.8K 0.39% 61
2024
Q4
$446K Buy
+857
New +$471K 0.32% 62

Other funds holding TMO

Lionshead Wealth Management's TMO Position: Q2 2026 in Review

Lionshead Wealth Management increased its Thermo Fisher Scientific (TMO) stake by 110% in Q2 2026, buying an estimated $957K and bringing the position to 3,811 shares worth $1.91M. The position accounts for 1.24% of the portfolio, ranked #25.

Lionshead Wealth Management first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Lionshead Wealth Management held 3,811 shares of Thermo Fisher Scientific worth $1.91M as of Q2 2026.
  • Lionshead Wealth Management bought 1,993 Thermo Fisher Scientific shares in Q2 2026, an estimated $957K.
  • Thermo Fisher Scientific made up 1.24% of Lionshead Wealth Management's portfolio in Q2 2026, its #25 holding.
  • Lionshead Wealth Management first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Lionshead Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.